Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 427 of 1,261

  1. US 10633370

    Phenyl indole allosteric inhibitors of p97 ATPase

    The Regents of the University of California · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  2. US 10632114

    Pyruvate kinase activators for use in therapy

    Agios Pharmaceuticals, Inc. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  3. US 10633411

    Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

    The Board of Regents of the University of Texas System · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  4. US 10632211

    Demethylation to treat eye disease

    The Regents of the University of California · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  5. US 10633445

    T-cell receptor (TCR)-binding antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  6. US 10632173

    Formulations and methods of use for alpha connexin C-terminal (ACT) peptides

    FIRSTRING RESEARCH, INC. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  7. US 10633451

    Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine

    Ludwig-Maximilians-Universitat Munchen · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  8. US 10633363

    EPAC1 activators as HIV latency reversal agents (LRA)

    The Board of Regents of the University of Texas System · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  9. US 10633643

    Engineered Clostridium botulinum toxin adapted to deliver molecules into selected cells

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  10. US 10633632

    Human disc tissue

    DiscGenics, Inc. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  11. US 10633493

    Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation

    Northwestern University · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  12. US 10633447

    Soluble engineered monomeric Fc

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  13. US 10633442

    Antibodies to connexin 43 (Cx43) hemichannels and methods of use thereof to inhibit Cx43 hemichannel opening

    The Board of Regents of the University of Texas System · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  14. US 10633434

    Anti-C5 antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  15. US 10633381

    KRas G12C inhibitors

    Mirati Therapeutics, Inc. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  16. US 10633386

    BET protein degraders

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  17. US 10633344

    Multiple-component solid phases containing at least one active pharmaceutical ingredient

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  18. US 10633345

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  19. US 10632199

    Long-acting polymeric delivery systems

    Heron Therapeutics, Inc. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  20. US 10632251

    Device, system and methods for the oral delivery of therapeutic compounds

    Rani Therapeutics, LLC · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  21. US 10632255

    Drug infusion device

    MILESTONE SCIENTIFIC, INC. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  22. US 10632185

    Chimeric west nile/zika viruses and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  23. US 10632184

    Compositions and methods for stabilizing alphaviruses with improved formulations

    Takeda Vaccines, Inc. · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  24. US 10632198

    Pharmaceutical composition comprising brinzolamide

    SENTISS PHARMA PRIVATE LIMITED · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.